SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-14-041530
Filing Date
2014-07-03
Accepted
2014-07-03 16:35:54
Documents
2
Group Members
D. E. SHAW & CO., L.P.DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A v383241_sc13da.htm SC 13D/A 94757
2 EXHIBIT 1 v383241_ex-1.htm EX-1 6026
  Complete submission text file 0001144204-14-041530.txt   102520
Mailing Address 120 WEST FORTY-FIFTH STREET 39TH FLOOR NEW YORK NY 10036
Business Address 120 WEST FORTY-FIFTH STREET 39TH FLOOR NEW YORK NY 10036 (212) 478-0000
D. E. Shaw Valence Portfolios, L.L.C. (Filed by) CIK: 0001294704 (see all company filings)

IRS No.: 134046559 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Subject) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85529 | Film No.: 14961134
SIC: 2834 Pharmaceutical Preparations